1. Home
  2. PMEC vs CNSY Comparison

PMEC vs CNSY Comparison

Compare PMEC & CNSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primech Holdings Ltd.

PMEC

Primech Holdings Ltd.

N/A

Current Price

$0.30

Market Cap

20.7M

Sector

N/A

ML Signal

N/A

Logo Cerenome Inc. Common Stock

CNSY

Cerenome Inc. Common Stock

N/A

Current Price

$0.66

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMEC
CNSY
Founded
1984
1996
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.7M
20.6M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
PMEC
CNSY
Price
$0.30
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $27.75
AVG Volume (30 Days)
19.8K
★ 1.6M
Earning Date
07-24-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.61
EPS
★ N/A
N/A
Revenue
N/A
★ $5,213,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$414.61
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.30
$0.78
52 Week High
$1.37
$4.25

Technical Indicators

Market Signals
Indicator
PMEC
CNSY
Relative Strength Index (RSI) 26.69 19.89
Support Level N/A N/A
Resistance Level $0.79 $2.28
Average True Range (ATR) 0.05 0.38
MACD -0.01 -0.09
Stochastic Oscillator 7.34 1.65

Price Performance

Historical Comparison
PMEC
CNSY

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a Singapore-based facilities services and AI robotics group with operations in Singapore and Hong Kong. Through its subsidiaries, the company provides integrated facilities management, cleaning and stewarding services to the public and private sectors, serving airports, educational institutions, healthcare facilities, commercial buildings and hospitality venues. It also develops HYTRON, an autonomous restroom-cleaning robot that uses AI perception and robotic manipulation. In addition, the company operates HomeHelpy, a digital platform for booking home services for consumers.

About CNSY Cerenome Inc. Common Stock

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Share on Social Networks: